July 23, 2016 7:12 PM ET


Company Overview of The Translational Genomics Research Institute

Key Executives for The Translational Genomics Research Institute

NameBoard RelationshipsTitleAge
Jeffrey M. Trent Ph.D.84 RelationshipsFounder, President, Research Director and Director--
David LaVergne No RelationshipsVice President of Finance--
Tess Burleson MBA, CPA17 RelationshipsChief Operating Officer and President of TGen Health Ventures--
Michael Bassoff No RelationshipsPresident of TGen Foundation--
David Azorsa Ph.D.No RelationshipsUnit Head of Biological Therapeutics Lab - Pharmaceutical Genomics Division--
View More Key Executives

The Translational Genomics Research Institute Board Members*

NameBoard RelationshipsPrimary CompanyAge
Jeffrey M. Trent Ph.D. 84 RelationshipsThe Translational Genomics Research Institute--
Janet D. Rowley M.D. 29 RelationshipsThe Translational Genomics Research Institute--
Jeffrey Moorad 51 RelationshipsThe Translational Genomics Research Institute60
Richard L. Boals 62 RelationshipsBlue Cross and Blue Shield of Arizona, Inc.--
Susan Clark-Johnson 76 RelationshipsPhoenix Newspapers, Inc.69
View All Board Members

The Translational Genomics Research Institute Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D.Janet D. Rowley29 Relationships9 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
The Translational Genomics Research Institute CEO Compensation
Industry Average


Cleveland BioLabs, Inc. Announces Executive Changes
July 22, 2016 8:22 PM ET
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas Reed as M. D, Effective July 21, 2016
July 22, 2016 8:18 PM ET
ContraFect Corporation Appoints Steven C. Gilman as President and Chief Executive Officer
July 21, 2016 9:32 PM ET
William R. Ringo Intends to Resign from Mirati Therapeutics, Inc.'s Board of Directors
July 21, 2016 8:03 PM ET
Biostage Appoints Harout Dersimonian as Chief Scientific Officer to Oversee Cell Biology, Materials Science and Other Research Underlying its Organ Implant Development
July 21, 2016 12:56 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Translational Genomics Research Institute, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.